UCL School of Life and Medical Sciences

2013

• Berghöfer P, Fragkos KC, Baxter JP, Forbes A, Joly F, Heinze H, Loth S, Pertkiewicz M, Messing B, Jeppesen PB (2013). Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL™) scale. Clinical Nutrition, , - . doi:10.1016/j.clnu.2012.12.001
• Nathan I, Fragkos KC, Forbes A (2013). Correlates of IBD fatigue: a meta-analysis and systematic review. Journal of Crohn's and Colitis, 7(Supplement 1), S227 - . doi:10.1016/S1873-9946(13)60563-2

2012

• Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, Bond G, Gupte G, Pertkiewicz M, Steiger E, Forbes A, Van Gossum A, Pinna AD, ESPEN (2012). Outcome on home parenteral nutrition for benign intestinal failure: A review of the literature and benchmarking with the European prospective survey of ESPEN. CLINICAL NUTRITION, 31(6), 831 - 845. doi:10.1016/j.clnu.2012.05.004
• Benjamin JL, Hedin CRH, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, Pessoa-Lopes P, Mathew CG, Sanderson J, Hart AL, Kamm MA, Knight SC, Forbes A, Stagg AJ, Lindsay JO, Whelan K (2012). Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. INFLAMMATORY BOWEL DISEASES, 18(6), 1092 - 1100. doi:10.1002/ibd.21864
• Al-Sulttan FM, Fragkos KC, Bogdanos DP, Forbes A (2012). A Systematic Review and Meta-Analysis of Pancreatic Autoantibody's (Pab) Diagnostic Accuracy vs Standard Diagnosis in Patients With Inflammatory Bowel Disease. Gastroenterology, 142(5(Suppl 1)), S778 - S779. doi:10.1016/S0016-5085(12)63018-2
• Wong S, Graham A, Green D, Hirani SP, Grimble G, Forbes A (2012). Meal provision in a UK National Spinal Injury Centre: a qualitative audit of service users and stakeholders.. Spinal Cord, 50(10), 772 - 777. doi:10.1038/sc.2012.43
• Thoua NM, Abdel-Halim M, Forbes A, Denton CP, Emmanuel AV (2012). Fecal incontinence in systemic sclerosis is secondary to neuropathy.. Am J Gastroenterol, 107(4), 597 - 603. doi:10.1038/ajg.2011.399
• Wong S, Graham A, Harini SP, Grimble G, Forbes A (2012). Profile and prevalence of malnutrition in children with spinal cord injuries-assessment of the Screening Tool for Assessment of Malnutrition in Paediatrics (STAMP).. Spinal Cord, 50(1), 67 - 71. doi:10.1038/sc.2011.139
• Wong S, Derry F, Jamous A, Hirani SP, Grimble G, Forbes A (2012). Validation of the spinal nutrition screening tool (SNST) in patients with spinal cord injuries (SCI): result from a multicentre study.. Eur J Clin Nutr, 66(3), 382 - 387. doi:10.1038/ejcn.2011.209
• Wong SSH, Derry F, Jamous A, Harini S, Grimble G, Forbes A (2012). IS NUTRITIONAL RISK ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES SUCH AS LENGTH OF STAY AND MORTALITY IN SPINAL CORD INJURED PATIENTS ADMITTED TO A SPINAL CENTRE?. GUT, 61, A89 - A89. doi:10.1136/gutjnl-2012-302514b.39
• Wong SSH, Spillman L, Doraikannu J, Graham A, Green D, Grimble G, Forbes A (2012). A RE-AUDIT TO EVALUATE THE USE OF THE SPINAL NUTRITION SCREENING TOOL IN THE NATIONAL SPINAL INJURIES CENTRE (NSIC) AT STOKE MANDEVILLE HOSPITAL. GUT, 61, A89 - A89. doi:10.1136/gutjnl-2012-302514b.38
• Wong SSH, Graham A, Jamous A, Spillman L, Grimble G, Forbes A (2012). DIETARY INTERVENTION FOR INDIVIDUALS WITH SPINAL CORD INJURIES-A 2 YEAR REPORT ON THE SPINAL CLINIC FOR OBESE OUT-PATIENT PROJECT (SCOOP). GUT, 61, A96 - A96. doi:10.1136/gutjnl-2012-302514b.57
• Hamad A, Fragkos KC, Forbes A (2012). Probiotics for Prevention of Radiation Induced Bowel Disease: New Findings and Updated Meta-Analysis. Annals of Oncology, 23(Suppl 4), iv66 - iv66. doi:10.1093/annonc/mds153
• Balogun N, Forbes A, Widschwendter M, Lanceley A (2012). Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction.. Int J Gynecol Cancer, 22(6), 1089 - 1095. doi:10.1097/IGC.0b013e318256e4d3
• Wong S, Derry F, Graham A, Grimble G, Forbes A (2012). An audit to assess awareness and knowledge of nutrition in a UK spinal cord injuries centre.. Spinal Cord, 50(6), 446 - 451. doi:10.1038/sc.2011.180
• Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'Keefe SJD, Forbes A, Heinze H, Joelsson B (2012). Teduglutide Reduces Need for Parenteral Support Among Patients With Short Bowel Syndrome With Intestinal Failure. GASTROENTEROLOGY, 143(6), 1473 - +. doi:10.1053/j.gastro.2012.09.007

2011

• Fragkos K, Forbes A (2011). Was citrulline first a laxative substance? The truth about modern citrulline and its isolation. Nihon ishigaku zasshi / Journal of Japanese history of medicine, 57(3), 275 - 292.
• Fragkos KC, Al-Sulttan FM, Mookerjee RP, Winstanley A, Forbes A (2011). Review of the literature and description of a case of Sclerosing Encapsulating Peritonitis requiring home parenteral nutrition. Zeitschrift für Gastroenterologie, 49(12), 1543 - 1548. doi:10.1055/s-0031-1281847
• Ahmadi R, Mordan N, Forbes A, Day RM (2011). Enhanced attachment, growth and migration of smooth muscle cells on microcarriers produced using thermally induced phase separation.. Acta Biomater, 7(4), 1542 - 1549. doi:10.1016/j.actbio.2010.12.022
• Wong SSH, Derry F, Grimble G, Forbes A (2011). How do spinal cord injury centres manage malnutrition? A cross-sectional survey of 12 regional centres in the United Kingdom and Ireland. Spinal Cord, Spinal Cord advance online publication 18 October 2011; doi: 10.1038/sc.2011.118(Advanced online publication), - . doi:10.1038/sc.2011.118
• Fragkos K, Forbes A (2011). Digestion and absorption of nutrients. In Sobotka L, Allison S, Forbes A, Ljungqvist O, Pertkiewicz M, Meier R, Soeters PB (Ed.), Basics in Clinical Nutrition (pp. 83 - 96). : Galen.
• Forbes A, Goldesgeyme E, Paulon E (2011). Nutrition in Inflammatory Bowel Disease. JPEN-PARENTER ENTER, 35(5), 571 - 580. doi:10.1177/0148607111413599
• Papadia C, Louwagie J, Del Rio P, Grooteclaes M, Coruzzi A, Montana C, Franze A, Novelli M, Bordi C, Bryan W, Atkin W, Forbes A (2011). MODULATE COLITIS SURVEILLANCE: FOXE1 AND SYNE1 HYPERMETHYLATION IN COLITIS ASSOCIATED COLORECTAL CANCER (CAC). DIGEST LIVER DIS, 43, S132 - S133.
• Quilliot D, Forbes A, Dubois F, Gueant JL, Ziegler O (2011). Carotenoid deficiency in chronic pancreatitis: the effect of an increase in tomato consumption. EUR J CLIN NUTR, 65(2), 262 - 268. doi:10.1038/ejcn.2010.232
• Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, Gabe S, Hebuterne X, Gambarara M, Gottrand F, Cuerda C, Thul P, Messing B, Goulet O, Staun M, Van Gossum A, European Soc Clinical Nutr & Metab (2011). Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. GUT, 60(1), 17 - 25. doi:10.1136/gut.2010.223255
• Ng SC, Benjamin JL, McCarthy NE, Hedin CRH, Koutsoumpas A, Plamondon S, Price CL, Hart AL, Kamm MA, Forbes A, Knight SC, Lindsay JO, Whelan K, Stagg AJ (2011). Relationship Between Human Intestinal Dendritic Cells, Gut Microbiota, and Disease Activity in Crohn's Disease. INFLAMM BOWEL DIS, 17(10), 2027 - 2037. doi:10.1002/ibd.21590

2010

• Keshaw H, Thapar N, Burns AJ, Knowles J, Forbes A, Day RM (2010). Microporous collagen spheres produced via thermally induced phase separation for tissue regeneration. Acta Biomaterialia, 6(3), 1158 - 1166. doi:10.1016/j.actbio.2009.08.044
• Foong KS, Patel R, Forbes A, Day RM (2010). Anti-TNF-alpha-Loaded Microspheres as a Prospective Novel Treatment for Crohn's Disease Fistulae. Tissue Engineering, , 1 - 10. doi:10.1089/ten.tec.2009.0599
• Keshaw H, Foong KS, Forbes A, Day RM (2010). Perianal Fistulae in Crohn’s Disease: Current and Future Approaches to Treatment. Inflammatory Bowel Diseases, 16(5), 870 - 880.
• Smith PJ, Marks DJ, Forbes A (2010). Parenteral nutrition.. Br J Hosp Med (Lond), 71(12), M185 - M189.
• Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S, Vukcevic D, Barnes C, Conrad DF, Giannoulatou E, Holmes C, Marchini JL, Stirrups K, Tobin MD, Wain LV, Yau C, Aerts J, Ahmad T, Andrews TD, Arbury H, Attwood A, Auton A, Ball SG, Balmforth AJ, Barrett JC, Barroso I, Barton A, Bennett AJ, Bhaskar S, Blaszczyk K, Bowes J, Brand OJ, Braund PS, Bredin F, Breen G, Brown MJ, Bruce IN, Bull J, Burren OS, Burton J, Byrnes J, Caesar S, Clee CM, Coffey AJ, Connell JMC, Cooper JD, Dominiczak AF, Downes K, Drummond HE, Dudakia D, Dunham A, Ebbs B, Eccles D, Edkins S, Edwards C, Elliot A, Emery P, Evans DM, Evans G, Eyre S, Farmer A, Ferrier IN, Feuk L, Fitzgerald T, Flynn E, Forbes A, Forty L, Franklyn JA, Freathy RM, Gibbs P, Gilbert P, Gokumen O, Gordon-Smith K, Gray E, Green E, Groves CJ, Grozeva D, Gwilliam R, Hall A, Hammond N, Hardy M, Harrison P, Hassanali N, Hebaishi H, Hines S, Hinks A, Hitman GA, Hocking L, Howard E, Howard P, Howson JMM, Hughes D, Hunt S, Isaacs JD, Jain M, Jewell DP, Johnson T, Jolley JD, Jones IR, Jones LA, Kirov G, Langford CF, Lango-Allen H, Lathrop GM, Lee J, Lee KL, Lees C, Lewis K, Lindgren CM, Maisuria-Armer M, Maller J, Mansfield J, Martin P, Massey DCO, McArdle WL, McGuffin P, McLay KE, Mentzer A, Mimmack ML, Morgan AE, Morris AP, Mowat C, Myers S, Newman W, Nimmo ER, O'Donovan MC, Onipinla A, Onyiah I, Ovington NR, Owen MJ, Palin K, Parnell K, Pernet D, Perry JRB, Phillips A, Pinto D, Prescott NJ, Prokopenko I, Quail MA, Rafelt S, Rayner NW, Redon R, Reid DM, Renwick A, Ring SM, Robertson N, Russell E, St Clair D, Sambrook JG, Sanderson JD, Schuilenburg H, Scott CE, Scott R, Seal S, Shaw-Hawkins S, Shields BM, Simmonds MJ, Smyth DJ, Somaskantharajah E, Spanova K, Steer S, Stephens J, Stevens HE, Stone MA, Su Z, Symmons DPM, Thompson JR, Thomson W, Travers ME, Turnbull C, Valsesia A, Walker M, Walker NM, Wallace C, Warren-Perry M, Watkins NA, Webster J, Weedon MN, Wilson AG, Woodburn M, Wordsworth BP, Young AH, Zeggini E, Carter NP, Frayling TM, Lee C, McVean G, Munroe PB, Palotie A, Sawcer SJ, Scherer SW, Strachan DP, Tyler-Smith C, Brown MA, Burton PR, Caulfield MJ, Compston A, Farrall M, Gough SCL, Hall AS, Hattersley AT, Hill AVS, Mathew CG, Pembrey M, Satsangi J, Stratton MR, Worthington J, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Parkes M, Rahman N, Todd JA, Samani NJ, Donnelly P, Wellcome Trust Case Control (2010). Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. NATURE, 464(7289), 713 - U86. doi:10.1038/nature08979
• Foong KS, Patel R, Forbes A, Day RM (2010). Anti-tumor necrosis factor-alpha-loaded microspheres as a prospective novel treatment for Crohn's disease fistulae.. Tissue Eng Part C Methods, 16(5), 855 - 864. doi:10.1089/ten.TEC.2009.0599
• Benjamin JL, Hedin CRH, Koutsoumpas A, Ng SC, Hart AL, Kamm MA, Sanderson JD, Knight SC, Forbes A, Stagg AJ, Whelan K, Lindsay JO (2010). NO CLINICAL BENEFIT OF PREBIOTICS IN THE TREATMENT OF ACTIVE CROHN'S DISEASE: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL. doi:10.1136/gut.2009.208934c
• Thoua NM, Bunce C, Brough G, Forbes A, Emmanuel AV, Denton CP (2010). Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre.. Rheumatology (Oxford), 49(9), 1770 - 1775. doi:10.1093/rheumatology/keq147

2009

• Keshaw H, Georgiou G, Blaker JJ, Forbes A, Knowles JC, Day RM (2009). Assessment of Polymer/Bioactive Glass-Composite Microporous Spheres for Tissue Regeneration Applications. Tissue Engineering: Part A, 15(7), 1451 - 1461. doi:10.1089/ten.tea.2008.0203
• Staun M, Pironi L, Bozzetti F, Baxter J, Forbes A, Joly F, Jeppesen P, Moreno J, Hebuterne X, Pertkiewicz M, Muhlebach S, Shenkin A, Van Gossum A (2009). ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients. CLIN NUTR, 28(4), 467 - 479. doi:10.1016/j.clnu.2009.04.001
• Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C (2009). ESPEN Guidelines on Parenteral Nutrition: Intensive care. CLIN NUTR, 28(4), 387 - 400. doi:10.1016/j.clnu.2009.04.024
• Taylor SA, Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Forbes A, Cohen R, Windsor A, Obichere A, Hansmann A, Rajan J, Novelli M, Halligan S (2009). Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.. Radiology, 251(2), 369 - 379. doi:10.1148/radiol.2512081292
• Forbes A (2009). Iron and parenteral nutrition.. Gastroenterology, 137(5 Suppl), S47 - S54. doi:10.1053/j.gastro.2009.08.013
• Forbes A, Marie I (2009). Gastrointestinal complications: the most frequent internal complications of systemic sclerosis.. Rheumatology (Oxford), 48 Suppl 3, iii36 - iii39. doi:10.1093/rheumatology/ken485
• Bozzetti F, Forbes A (2009). The ESPEN clinical practice guidelines on Parenteral Nutrition: Present status and perspectives for future research. CLIN NUTR, 28(4), 359 - 364. doi:10.1016/j.clnu.2009.05.010

2008

• Koak Y, Gertner D, Forbes A, Ribeiro BF (2008). Idiopathic sclerosing peritonitis. EUR J GASTROEN HEPAT, 20(2), 148 - 150.
• Onnie CM, Fisher SA, Prescott NJ, Mirza MM, Green P, Sanderson J, Forbes A, Lewis CM, Mathew CG (2008). Diverse effects of the CARD15 and IBD5 loci on clinical phenotype in 630 patients with Crohn's disease. EUR J GASTROEN HEPAT, 20(1), 37 - 45.
• Koutsoumpas A, Hedin CRH, Ng SC, Kamm MA, Sanderson JD, Knight SC, Stagg AJ, Forbes A, Lindsay JO, Whelan K (2008). Smokers with active crohn's disease have differences in the concentration and proportion of key bacterial groups of the faecal microbiota.
• Johnson MW, Das P, Rippingale C, Forbes A, Ciclitira PJ, Nicholls R (2008). The outcome of pouch surgery in older patients.
• Haycock A, Hoare J, Patel J, Ralphs S, Forbes A (2008). Oral ciclosporin for chronically active steroid-dependent ulcerative colitis.
• Abdullahi M, Jimenez IO, Pavlidis C, Siakouli P, Forbes A (2008). Comparison of a simple global rating with established scoring systems for inflammatory bowel disease.
• Hedin CRH, Koutsoumpas A, Forbes A, Sanderson J, Stagg AJ, Knight SC, Whelan K, Lindsay JO (2008). Factors that limit recruitment to clinical trials in crohn's disease.
• Mawdsley JE, Hollington P, Bassett P, Windsor AJ, Forbes A, Gabe SM (2008). An analysis of predictive factors for healing and mortality in patients with enterocutaneous fistulas. ALIMENT PHARM THER, 28(9), 1111 - 1121. doi:10.1111/j.1365-2036.2008.03819.x
• Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, Prescott NJ, Nimmo ER, Massey D, Berzuini C, Johnson C, Barrett JC, Cummings FR, Drummond H, Lees CW, Onnie CM, Hanson CE, Blaszczyk K, Inouye M, Ewels P, Ravindrarajah R, Keniry A, Hunt S, Carter M, Watkins N, Ouwehand W, Lewis CM, Cardon L, Lobo A, Forbes A, Sanderson J, Jewell DP, Mansfield JC, Deloukas P, Mathew CG, Parkes M, Satsangi J, Wellcome Trust Case Control Consor (2008). Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. NAT GENET, 40(6), 710 - 712. doi:10.1038/ng.145
• Culkin A, Gabe SM, Bjarnason I, Grimble G, Madden AM, Forbes A (2008). A double-blind, randomized, controlled crossover trial of glutamine supplementation in home parenteral nutrition. EUR J CLIN NUTR, 62(5), 575 - 583. doi:10.1038/sj.ejcn.1602754
• Ng SC, Koutsoumpas A, Hedin CR, McCarthy NE, Plamondon S, Kamm MA, Knight SC, Forbes A, Lindsay JO, Whelan K, Stagg AJ (2008). Production of il-10 by colonic dendritic cells is associated with higher concentrations of faecal microbiota in patients with active crohn's disease.
• Johnson MW, Gonzalez-Cinca N, Ellis JR, Forbes A, Ciclitira PJ, Nicholls R (2008). The role of macrophages and lymphocytes in acute pouchitis.
• Blaker JJ, Pratten J, Ready D, Knowles JC, Forbes A, Day RM (2008). Assessment of antimicrobial microspheres as a prospective novel treatment targeted towards the repair of perianal fistulae. Aliment.Pharmacol.Ther., 28(5), 614 - 622.

2007

• Lewis CM, Whitwell SCL, Forbes A, Sanderson J, Mathew CG, Marteau TM (2007). Risk estimation for common complex genetic disorders: using genetic, environmental and family history information in Crohn's disease.
• Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans D, Leung HT, Marchini JL, Morris AP, Spencer CCA, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskvina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Farmer A, Williamson R, McGuffin P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop DT, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Dixon RJ, Mangino M, Stevens S, Thompson JR, Bredin F, Tremelling M, Parkes M, Drummond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Mathew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfield JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Lathrop GM, Connell J, Dominiczak A, Marcano CAB, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue MZ, Caulfield M, Farrall M, Barton A, Bruce IN, Donovan H, Eyre S, Gilbert PD, Hider SL, Hinks AM, John SL, Potter C, Silman AJ, Symmons DPM, Thomson W, Worthington J, Dunger DB, Widmer B, Frayling TM, Freathy RM, Lango H, Perry JRB, Shields BM, Weedon MN, Hattersley AT, Hitman GA, Walker M, Elliott KS, Groves CJ, Lindgren CM, Rayner NW, Timpson NJ, Zeggini E, Newport M, Sirugo G, Lyons E, Vannberg F, Brown MA, Franklyn JA, Heward JM, Simmonds MJ, Hill AVS, Bradbury LA, Farrar C, Pointon JJ, Wordsmith P, Gough SCL, Seal S, Stratton MR, Rahman N, Ban M, Goris A, Sawcer SJ, Compston A, Conway D, Jallow M, Bumpstead SJ, Chaney A, Downes K, Ghori MJR, Gwilliam R, Inouye M, Keniry A, King E, McGinnis R, Potter S, Ravindrarajah R, Whittaker P, Withers D, Easton D, Pereira-Gale J, Hallgrimsdottir IB, Howie BN, Su Z, Teo YY, Vukcevic D, Bentley D, Caulfield M, Mathew CG, Worthington J, Wellcome Trust Case Control Consortium , Biol RA Genet & Genom Study Syndicate , Breast Canc Susceptib Collaborat (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. NATURE, 447(7145), 661 - 678. doi:10.1038/nature05911
• Datta VK, Dann S, Engledow A, Privitera A, Cohen R, Forbes A, Windsor A (2007). Can enterocutaneous fistula be effectively managed in a regional unit?.
• Wallis K, Walters JRF, Forbes A (2007). Review article: glucagon-like peptide 2 - current applications and future directions. ALIMENT PHARM THER, 25(4), 365 - 372. doi:10.1111/j.1365-2036.2006.03193.x
• Forbes A (2007). Global guidelines for nutrition support. LANCET, 370(9603), 1906 - 1906.
• Lewis CM, Whitwell SCL, Forbes A, Sanderson J, Mathew CG, Marteau TM (2007). Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J MED GENET, 44(11), 689 - 694. doi:10.1136/jmg.2007.051672
• Bell AJG, Price AB, Forbes A, Ciclitira PJ, Nicholls RJ (2007). Pre-pouch ileitis. ALIMENT PHARM THER, 26(6), 963 - 964. doi:10.1111/j.1365-2036.2007.03436.x
• Mansfield JC, Parkes M, Hawthorne AB, Forbes A, Probert CSJ, Perowne RC, Cooper A, Zeldis JB, Manning DC, Hawkey CJ (2007). A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease. ALIMENT PHARM THER, 26(3), 421 - 430. doi:10.1111/j.1365-2036.2007.03385.x
• Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, Khawaja SA, Bagnall R, Burke DA, Todhunter CE, Ahmad T, Onnie CM, McArdle W, Strachan D, Bethel G, Bryan C, Lewis CM, Deloukas P, Forbes A, Sanderson J, Jewell DP, Satsangi J, Mansfield JC, Cardon L, Mathew CG, Wellcome Trust Case Control Consor (2007). Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. NAT GENET, 39(7), 830 - 832. doi:10.1038/ng2061
• Steinhart AH, Forbes A, Mills EC, Rodgers-Gray BS, Travis SPL (2007). Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease. ALIMENT PHARM THER, 25(12), 1389 - 1399. doi:10.1111/j.1365-2036.2007.03324.x
• Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, Nimmo ER, Drummond H, Onnie CM, Prescott NJ, Sanderson J, Bredin F, Berzuini C, Forbes A, Lewis CM, Cardon L, Deloukas P, Jewell D, Mathew CG, Parkes M, Satsangi J (2007). IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. GASTROENTEROLOGY, 132(5), 1657 - 1664. doi:10.1053/j.gastro.2007.02.051
• Prescott NJ, Fisher SA, Franke A, Onnie CM, Hampe J, Todhunter CE, Soars D, Sanderson J, Forbes A, Mansfield J, Lewis CM, Schreiber S, Mathew CG (2007). A non-synonymous SNP in an autophagy-related gene is associated with Crohn's disease.
• Pearce AV, Fisher SA, Prescott NJ, Onnie CM, Pattni R, Green P, Forbes A, Mansfield J, Sanderson J, Schreiber S, Lewis CM, Mathew CG (2007). Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population. INT J COLORECTAL DIS, 22(4), 419 - 424. doi:10.1007/s00384-006-0151-4
• Windsor A, Forbes A (2007). Is the multidisciplinary team essential for the future management of patients with inflammatory bowel disease?. Colorectal Dis, 9(6), 478 - 479. doi:10.1111/j.1463-1318.2007.01293.x
• Banks C, Forbes A (2007). Topical treatment of ulcerative colitis. Some reflections.. Dig Liver Dis, 39(4), 338 - 341. doi:10.1016/j.dld.2006.11.001
• Forbes A (2007). Parenteral nutrition.. Curr Opin Gastroenterol, 23(2), 183 - 186. doi:10.1097/MOG.0b013e328012134a
• Fisher SA, Mirza MM, Onnie CM, Soars D, Lews CM, Prescott NJ, Mathew CG, Sanderson J, Forbes A, Todhunter C, Donaldson P, Mansfield J (2007). Combined evidence from three large British association studies rejects TUCAN/CARD8 as an IBD susceptibility gene. GASTROENTEROLOGY, 132(5), 2078 - 2080. doi:10.1053/j.gastro.2007.03.086

2006

• Polymeros D, Bogdanos D, Day R, Arioli D, Vergani D, Forbes A (2006). Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?. Gastroenterology, 131(1), 85 - 96. doi:10.1053/j.gastro.2006.04.021
• Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A (2006). Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis.. Gastroenterology, 130(4), 1030 - 1038. doi:10.1053/j.gastro.2005.12.035
• Keshaw H, Sibbons PD, Forbes A, Day RM (2006). Development of a collagen-ceramic composite for fistula repair. Gut, 55, A86 - A87.
• Principi M, Day R, Marangi S, Burattini O, De F, V I, M P, A P, C F, A D, Leo A F, A I, E (2006). Differential immunohistochemical expression of syndecan-1 and tumor necrosis factor alpha in colonic mucosa of patients with Crohn's disease. Immunopharmacol.Immunotoxicol., 28(2), 185 - 195.
• Lindsay JO, Whelan K, Stagg AJ, Gobin P, Al-Hassi HO, Rayment N, Kamm M, Knight SC, Forbes A (2006). The clinical, microbiological and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease.. Gut, 55, 348 - 355.
• Reid EP, Forbes A, Sanderson J, Mathew CG, Lewis C, Marteau TM (2006). Recruiting first-degree relatives for prevention research: a comparison of clinician and proband-led methods of contact in Crohn's disease. EUR J HUM GENET, 14(12), 1263 - 1268. doi:10.1038/sj.ejhg.5201699
• Lloyd DAJ, Vega R, Bassett P, Forbes A, Gabe SM (2006). Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. ALIMENT PHARM THER, 24(8), 1231 - 1240. doi:10.1111/j.1365-2036.2006.03106.x
• Onnie C, Fisher SA, King K, Mirza M, Roberts R, Forbes A, Sanderson J, Lewis CM, Mathew CG (2006). Sequence variation, linkage disequilibrium and association with Crohn's disease on chromosome 5q31. GENES IMMUN, 7(5), 359 - 365. doi:10.1038/sj.gene.6364307
• Fisher SA, Hampe J, Onnie CM, Daly MJ, Curley C, Purcell S, Sanderson J, Mansfield J, Annese V, Forbes A, Lewis CM, Schreiber S, Rioux JD, Mathew CG (2006). Direct or indirect association in a complex disease: The role of SLC22A4 and SLC22A5 functional variants in Crohn disease. HUM MUTAT, 27(8), 778 - 785. doi:10.1002/humu.20358
• van Heel DA, Hunt KA, King K, Ghosh S, Gabe SM, Mathew CG, Forbes A, Playford RJ (2006). Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease. INFLAMM BOWEL DIS, 12(7), 598 - 605.
• Onnie CM, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, Mathew CG (2006). Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: A case-control and meta-analysis study. INFLAMM BOWEL DIS, 12(4), 263 - 271.
• Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchel R, Hawkey CJ, European Crohns Colitis Org ECCO (2006). European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. GUT, 55, - . doi:10.1136/gut.2005.081950c
• Travis SPL, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ, European Crohns Colitis Org ECCO (2006). European evidence based consensus on the diagnosis and management of Crohn's disease: current management. GUT, 55, - . doi:10.1136/gut.2005.081950b
• Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A (2006). Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.. Gastroenterology, 126, 451 - 459.
• Forbes A (2006). Parenteral nutrition.. Curr Opin Gastroenterol, 22(2), 160 - 164. doi:10.1097/01.mog.0000203869.22706.84
• Harbord MW, Marks DJ, Forbes A, Bloom SL, Day RM, Segal AW (2006). Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor. Aliment.Pharmacol.Ther., 24(4), 651 - 660.

2005

• Day RM, Maquet V, Boccaccini AR, Jerome R, Forbes A (2005). In vitro and in vivo analysis of macroporous biodegradable poly(D,L-lactide-co-glycolide) scaffolds containing bioactive glass. J.Biomed.Mater.Res.A, 75(4), 778 - 787. doi:10.1002/jbm.a.30433
• Marks D, Oukrif D, Novelli M, Forbes A, Segal AW, Harbord M (2005). Impaired acute inflammation in the terminal ileum of Crohn's patients.
• Barratt HS, Kalantzis C, Polymeros D, Forbes A (2005). Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status.. Alimentary Pharmacology and Therapeutics, 21, 141 - 147.
• Van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg A, Ahmad T, McGovern DPB, Onnie C, Negoro K, Goldthorpe S, Foxwell BMJ, Mathew CG, Forbes A, Jewell DP, Playford RJ (2005). Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.. The Lancet, 365(9473), 1794 - 1796. doi:10.1016/S0140-6736(05)66582-8
• Keshaw H, Forbes A, Day RM (2005). Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials, 26(19), 4171 - 4179. doi:10.1016/j.biomaterials.2004.10.021

2004

• Day RM, Boccaccini AR, Shurey S, Roether JA, Forbes A, Hench LL, Gabe SM (2004). Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials, 25(27), 5857 - 5866. doi:10.1016/j.biomaterials.2004.01.043
• Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A (2004). Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.. Gastroenterology, 126(2), 451 - 459. doi:10.1053/j.gastro.2003.11.010
• Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A (2004). Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.. Gut, 53, 1813 - 1816.
• Emmanuel AV, Stern J, Traesure J, Forbes A, Kamm MA (2004). Anorexia nervosa in gastrointestinal practice. European Journal of Gastroenterology and Hepatology, 16(11), 1135 - 1142.
• Day RM, Boccaccini AR, Maquet V, Shurey S, Forbes A, Gabe SM, Jerome R (2004). In vivo characterisation of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications. J.Mater.Sci.Mater.Med., 15(6), 729 - 734.

2003

• Probert CSJ, Hearing SD, Schreiber S, Kühbacher T, Ghosh S, Arnott IDR, Forbes A (2003). Infliximab in steroid-resistant ulcerative colitis – a randomised controlled trial.. Gut, 52, 998 - 1002.
• Day RM, Mitchell TJ, Knight SC, Forbes A (2003). Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine, 21(5), 224 - 233.

2002

• Day R, Harbord M, Segal A, Forbes A (2002). Differences in micro-vascular blood flow at sites of skin blistering may account for reduced leukocyte trafficking in Crohn's disease. GUT, 50, A77 - A77.
• Harbord M, Day R, Hankin A, Bloom S, Forbes A, Segal AW (2002). Neutrophil respiratory burst and tissue penetration are normal in CD during G-CSF administration. GUT, 50, A67 - A67.
• Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG (2002). The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.. Gastroenterology, 122, 867 - 874.

2001

• Hampe J, Cuthbert A, Croucher PJP, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJS, Bridger S, Van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG (2001). Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.. The Lancet, 357, 1925 - 1928.
• Harbord M, Day R, Bloom S, Knight S, Forbes A, Segal AW (2001). Neutrophil deficiency during acute inflammation in inflammatory bowel disease. GUT, 48, A20 - A20.
• Furlano RI, Anthony A, Day R, Brown A, McGarvey L, Thomson MA, Davies SE, Berelowitz M, Forbes A, Wakefield AJ, Walker-Smith JA, Murch SH (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138(3), 366 - 372.
• Day RM, Harbord M, Forbes A, Segal AW (2001). Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. Journal of Immunological Methods, 257(1-2), 213 - 220. doi:10.1016/S0022-1759(01)00467-7

1999

• Day R, Forbes A (1999). Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet, 354(9172), 62 - 65.
• Day RM, Hao X, Ilyas M, Daszak P, Talbot IC, Forbes A (1999). Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Arch., 434(2), 121 - 125.
• Day R, Ilyas M, Daszak P, Talbot I, Forbes A (1999). Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy. Dig.Dis.Sci., 44(12), 2508 - 2515.

1997

• Ilyas M, Novelli M, Wilkinson K, Tomlinson IPM, Abbasi AM, Forbes A, Talbot IC (1997). Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Duke's B colorectal cancers. Journal of Clinical Pathology, 50(3), 218 - 222.

1993

• Abbasi AM, Chester KA, Talbot IC, Macpherson AS, Boxer G, Forbes A, Malcolm ADB, Begent RHJ (1993). CD44 is associated with proliferation in normal and neoplastic human colorectal epitheial-cells. European Journal of Cancer, 29A(14), 1995 - 2002.

• Hamad A, Fragkos K, Forbes A (). Probiotics for prevention of radiation induced bowel disease: New findings and updated meta-analysis. Neurogastroenterology & Motility, 24(Suppl S2), 185 - 186. doi:10.1111/j.1365-2982.2012.01997.x
• Hamad A, Forbes A, Fragkos KC (). A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clinical Nutrition, , - . doi:10.1016/j.clnu.2013.02.004
• Taylor SA, Punwani S, Rodriguez-Justo M, Bainbridge A, Greenhalgh R, De Vita E, Forbes A, Cohen R, Windsor A, Obichere A, Hansmann A, Rajan J, Novelli M, Halligan S (). Dynamic contrast enhanced MRI of mural Crohn’s disease: Correlation with histological angiogenesis and inflammation-a pilot study. Radiology, , - .
• Wong SSH, Derry F, Jamous A, Hirani SP, Grimble G, Forbes A (). The prevalence of malnutrition in spinal cord injuries patients: a UK multicentre study. British Journal of Nutrition, , - . doi:10.1017/S0007114511006234